PURPOSE: We reviewed treatment outcomes and prognostic factors for @entity1 with @entity513 ( @entity513 ) treated with surgery and postoperative radiotherapy from 2005 to 2012. MATERIALS AND METHODS: A total of 16 @entity1 were identified and 15 eligible @entity1 were included in analysis. Median age was 61 years (range, 40 to 71 years) and 12 @entity1 (80%) were @entity1 . Twelve @entity1 (80%) had a @entity5 in the parotid gland, 9 (60%) had T3 or T4 disease, and 9 (60%) had positive @entity66 . All @entity1 underwent surgery and postoperative radiotherapy. Postoperative radiotherapy was delivered using 3-dimensional conformal radiotherapy or intensity-modulated radiotherapy. Locoregional failure-free survival (LRFFS), distant failure-free survival (DFFS), progression-free survival (PFS), and @entity1349 ( @entity1349 ) were calculated using the Kaplan-Meier method. Differences in survival based on risk factors were tested using a log-rank test. RESULTS: Median total radiotherapy dose was 60 Gy (range, 52.5 to 63.6 Gy). Four @entity1 received concurrent weekly chemotherapy with @entity900 . Among 10 @entity1 who underwent surgery with neck dissection, 7 received modified radical neck dissection. With a median follow-up time of 38 months (range, 24 to 105 months), 4-year rates were 86% for LRFFS, 51% for DFFS, 46% for PFS, and 93% for @entity1349 . Local failure was observed in 2 @entity1 (13%), and distant failure was observed in 7 (47%). The lung was the most common involved site of distant @entity3 . CONCLUSION: Surgery and postoperative radiotherapy in @entity513 @entity1 resulted in good local control, but high distant @entity3 remained a major challenge.

Postoperative radiotherapy in XXXX : a single institution experience.

@entity1 :: ('9606', 'Species') :: ['patients', 'men'] @entity66 :: ('MESH:D004194', 'Disease') :: ['nodal disease'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity900 :: ('MESH:D002945', 'Chemical') :: ['cisplatin'] @entity513 :: ('MESH:D044584', 'Disease') :: ['SDC', 'salivary ductal carcinoma'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival']
@entity513 :: (MESH:D044584,Disease) :: ['salivary ductal carcinoma']
